WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

THE IMPACT OF ALPELISIB “PI3K INHIBITOR” ON TNF/NLRP3/IL-1? SIGNALING PATHWAY IN METHOTREXATE-INDUCED HEPATOTOXICITY IN MICE

Rana M. Gamal*, Sara H. Hazem, Rania and R. Abdelaziz

ABSTRACT

Drug-induced liver injury (DILI) is one of the main causes of hepatotoxicity. Chemotherapeutic agents are the most common of these deleterious drug-induced injuries. Methotrexate (MTX), an antimetabolite, is most frequently used as a chemotherapeutic drug for for several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and several types of solid cancer and as an immunosuppressant in autoimmune illness. Since MTX is used so widely, a clear toxicity profile has developed, with hepatotoxicity being the most significant possible side effect. We studied the effect of alpelisib (ALP), a PI3K inhibitor, on the hepatotoxicity induced by methotrexate by targeting the TNF-α/ NLRP3/IL-1β pathway. The mice in this experiment were arbitrarily split into four groups: I) control; II) MTX (20 mg/kg); III) ALP (2.5 mg/kg) + MTX (20 mg/kg) and IV) ALP (5 mg/kg) + MTX (20 mg/kg). Where ALP was administered for 5 days of the experiment and MTX was administered for the last 4 days of the experiment, 2 h after ALP administration. The liver index was estimated via dailyrecording of the body weight changes. In addition, the TNF-α/NLRP3/IL-1β pathway was assessed in liver tissue by ELISA technique. The weight of mice was significantly reduced in MTX group compared to normal control group. On the other hand, liver index was significantly decreased in MTX group only. An evaluation of TNF-α/NLRP3/IL-1β signaling using ELISA showed that this pathway was activated by ALP given in the acute MTX induced hepatotoxicity. Where, ALP induced slight elevation in TNF-α and statistically significant elevation in NLRP3 and IL-1β. In conclusion, our results exclude TNF-

Keywords: ?/NLRP3/IL-1? inflammatory signaling pathway to be involved in PI3K inhibition mediated amelioration of MTX-indued hepatotoxicity.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More